Stock Earnings

Question 1

What are Soleno Therapeutics Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Soleno Therapeutics Inc has a total asset of $330, Net loss of $-175

Question 2

What are the key financial ratios for SLNO?

Accepted Answer

Soleno Therapeutics Inc's Current ratio is 3.88, has a Net margin is 0, sales per share of $0.

Question 3

How is Soleno Therapeutics Inc's revenue broken down by segment or geography?

Accepted Answer

Currently Soleno Therapeutics Inc data is not available.

Question 4

Is Soleno Therapeutics Inc profitable?

Accepted Answer

no, according to the latest financial statements, Soleno Therapeutics Inc has a net loss of $-175

Question 5

Does Soleno Therapeutics Inc have any liabilities?

Accepted Answer

yes, Soleno Therapeutics Inc has liability of 85

Question 6

How many outstanding shares for Soleno Therapeutics Inc?

Accepted Answer

Soleno Therapeutics Inc has a total outstanding shares of 45.7

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	98	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	1	--	--	--	--	--
Gross Profit	96	--	--	--	--	--
Selling, General & Admin	128	105	13	9	10	8
Research & Development	52	78	25	15	21	23
Operating Expenses	186	187	41	24	31	36
Other Non Operating Income (Expenses)	--	0	0	0	0	11
Pretax Income	-78	-175	-38	-24	-30	-24
Income Tax Expense	--	--	--	--	--	--
Net Income	-78	-175	-38	-24	-30	-24
Net Income Growth	-40%	361%	57.99%	-20%	25%	-20%
Shares Outstanding (Diluted)	54.92	40.17	16.49	8.4	5.32	4.17
Shares Change (YoY)	31%	144%	96%	57.99%	28%	83%
EPS (Diluted)	-1.42	-4.37	-2.36	-2.87	-5.81	-5.9
EPS Growth	-54%	85%	-18%	-51%	-2%	-56%
Free Cash Flow	-25	-69	-24	-20	-27	-25
Free Cash Flow Per Share	-0.45	-1.71	-1.45	-2.38	-5.07	-5.99
Gross Margin	97.95%	--	--	--	--	--
Operating Margin	-90.81%	0%	0%	0%	0%	0%
Profit Margin	-79.59%	0%	0%	0%	0%	0%
Free Cash Flow Margin	-25.51%	0%	0%	0%	0%	0%
EBITDA	-87	-186	-40	-23	-30	-35
EBITDA Margin	-88.77%	0%	0%	0%	0%	0%
D&A For EBITDA	2	1	1	1	1	1
EBIT	-89	-187	-41	-24	-31	-36
EBIT Margin	-90.81%	0%	0%	0%	0%	0%
Effective Tax Rate	--	--	--	--	--	--

Soleno Therapeutics Inc (SLNO) Price